Skip to main content
Equibles
NXGL logo

NXGL · Nexgel, Inc. · Webcasts, Transcripts & Audio

Track NXGL — free

Use NXGL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NXGL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.10 -0.23 (-4.32%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 17, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of June 30, 2026, the Company had an unrestricted cash balance of $0.5 million. For the six months ended June 30, 2026, the Company incurred a net loss of $4.5 million and had a net usage of cash in operating activities of $2,701 thousand. These conditions raise substantial doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 17, 2026
Market Cap
$2.60M
Shares
487,383
Volume · Oct 21 8714 Avg daily vol (7 sessions) 559.91K

Nexgel, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Nexgel, Inc. (NXGL), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY25 · Q3
2025-11-12
Nexgel, Inc. (NXGL) Q3 2025 Earnings Call Transcript
Positive tone Contract manufacturing growth iRhythm / Zio ECG partnership AbbVie / restarting device uncertainty
Revenue
$2.93M
▼ 0.2% YoY
Diluted EPS
$-1.60
Gross margin
42.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Nexgel, Inc. (NXGL) Q2 2025 Earnings Call Transcript
Confident tone Contract Manufacturing Growth Consumer Branded Products / Silly George Pipeline and Future Partnerships
Revenue
$2.88M
▲ 100.3% YoY
Diluted EPS
$-1.80
Gross margin
43.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-13
Nexgel, Inc. (NXGL) Q1 2025 Earnings Call Transcript
Confident tone Revenue and growth momentum Consumer product brand expansion Laser hair removal / hydrogel study
Revenue
$2.81M
▲ 121.6% YoY
Diluted EPS
$-1.80
Gross margin
42.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-24
Nexgel, Inc. (NXGL) Q4 2024 Earnings Call
Revenue
$3.04M*
▲ 181.4% YoY
Gross margin
37.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Nexgel, Inc. (NXGL) Q3 2024 Earnings Call Transcript
Confident tone Record Financial Results Laser Hair Removal / Medical Device Pipeline Silly George Brand Growth
Revenue
$2.94M
▲ 140.8% YoY
Diluted EPS
$-2.20
Gross margin
39.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-14
Nexgel, Inc. (NXGL) Q2 2024 Earnings Call Transcript
Confident tone Silly George acquisition STADA / Histasolv product launch AbbVie / RESONIC partnership
Revenue
$1.44M
▲ 23.4% YoY
Diluted EPS
$-2.80
Gross margin
20.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Nexgel, Inc. (NXGL) Q1 2024 Earnings Call Transcript
Confident tone Revenue Growth European Expansion / MDR Compliance Branded Consumer Products
Revenue
$1.27M
▲ 104.2% YoY
Diluted EPS
$-2.80
Gross margin
12.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-04-01
Nexgel, Inc. (NXGL) Q4 2023 Earnings Call Transcript
Positive tone AbbVie Resonic partnership Retail strategy MDR compliance and Europe expansion
Revenue
$1.08M*
▲ 106.7% YoY
Gross margin
-8.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Nexgel, Inc. (NXGL) Q3 2023 Earnings Call Transcript
Revenue
$1.22M
▲ 115% YoY
Diluted EPS
$-2.00
Gross margin
28.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-14
Nexgel, Inc. (NXGL) Q2 2023 Earnings Call Transcript
Revenue
$1.17M
▲ 108% YoY
Diluted EPS
$-2.40
Gross margin
15.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-15
Nexgel, Inc. (NXGL) Q1 2023 Earnings Call Transcript
Revenue
$620,000
▲ 56.6% YoY
Diluted EPS
$-3.00
Gross margin
-9.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-27
Nexgel, Inc. (NXGL) Q4 2022 Earnings Call
Revenue
$523,000*
▼ 1.7% YoY
Gross margin
5.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Nexgel, Inc. (NXGL) Q3 2022 Earnings Call
Revenue
$568,000
▲ 69.6% YoY
Diluted EPS
$-4.40
Gross margin
26.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
Nexgel, Inc. (NXGL) Q2 2022 Earnings Call
Revenue
$561,000
▲ 34.5% YoY
Diluted EPS
$-3.80
Gross margin
18.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-12
Nexgel, Inc. (NXGL) Q1 2022 Earnings Call
Revenue
$396,000
▲ 48.3% YoY
Diluted EPS
$-6.60
Gross margin
-5.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-21
Nexgel, Inc. (NXGL) Q4 2021 Earnings Call
Revenue
$532,000*
▲ 426.7% YoY
Gross margin
19.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–16 of 16 webcasts
Key facts CIK 1468929 CUSIP 65344E107 13F (30d) 1 filings 1 filers Visit website Investor relations